Peptide therapy for diabetes in NOD mice
- PMID: 7907681
- DOI: 10.1016/s0140-6736(94)91582-2
Peptide therapy for diabetes in NOD mice
Abstract
NOD mice spontaneously develop autoimmune diabetes that mimics insulin-dependent diabetes mellitus (IDDM) in man. A peptide of the 60 kDa heat shock protein (hsp60), designated p277, can serve as a target for diabetogenic T-cell clones, and diabetes was prevented by using the p277 peptide to turn off anti-p277 immunity early in life. We report that the p277 peptide, administered once, can arrest the autoimmune process even after it is far advanced. Successful therapy was associated with down-regulation of the autoimmune process and regression of islet inflammation. Thus the immune system is responsive to manipulation by a specific signal even in the face of a virulent, full-blown autoimmune process.
Comment in
-
IDDM: long honeymoon, sweet ending.Lancet. 1994 Mar 19;343(8899):684-5. doi: 10.1016/s0140-6736(94)91574-1. Lancet. 1994. PMID: 7907674 No abstract available.
-
Peptide therapy for diabetes.Lancet. 1994 May 7;343(8906):1168-9. doi: 10.1016/s0140-6736(94)90278-x. Lancet. 1994. PMID: 7910263 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous